Jazz Pharmaceuticals plc Derivative Asset
Jazz Pharmaceuticals plc (JAZZ) had Derivative Asset of $1.90 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets
us-gaap:DerivativeAssets · last filed 2026-08-03
- 2026-06-30: Derivative Asset $1.90M.
- 2026-03-31: Derivative Asset $0.00.
- 2025-12-31: Derivative Asset $6.30M.
| Period end | Derivative Asset |
|---|---|
| 2026-06-30 | $1.90M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 |
| 2025-12-31 | $6.30M 10-Q · filed 2026-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |